Brand tirzepatide
Recorded for Vytora Health · Injection, pen · every brand tirzepatide record
Price
Historical price evidence from October 2026. Current availability and prices are not verified. These figures are not a current offer.
| Term | Published rate | Charged today |
|---|---|---|
| Mounjaro — advertised retail month-to-month program Prescription required. Advertised retail figure; insurance may change actual cost. No selected invoice or medication-specific assigned pharmacy is established; shipping-policy charge conflict remains. Advertised“$1,399 / month Retail pricing · Month-to-month · Prescription required” | $1,399Published figure | Charged todayNot verified |
| Zepbound — advertised retail month-to-month program Prescription required. Advertised retail figure; insurance may change actual cost. No selected invoice or medication-specific assigned pharmacy is established; shipping-policy charge conflict remains. Advertised“$1,399 / month Retail pricing · Month-to-month · Prescription required” | $1,399Published figure | Charged todayNot verified |
Price sources
- Mounjaro — advertised retail month-to-month program · vytorahealth.com — read October 2026
- Zepbound — advertised retail month-to-month program · vytorahealth.com — read October 2026
Current availability of this program is not verified.
We earn nothing from this link. It opens Vytora Health's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Both |
| Cancellation | Recurring subscription charges continue each billing cycle until canceled by contacting support. Public refund policy says all sales are final and prescription products cannot be returned for reuse/resale; contact support about filling errors. Cancellation cutoff and refund/no-charge outcome if no prescription is issued are not established. https://vytorahealth.com/refund https://vytorahealth.com/faq |
| Membership | None. “No membership or hidden fees” |
| Consult fee | Included in program price; itemized amount is not published. The brand product pages explicitly include physician consultation and unlimited provider messaging. |
Recorded from vytorahealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. October 2026 — Vytora says its advertised plans include medication, physician consultation, supplies and ongoing provider support, with no membership fee. It names Wasef Health as the clinical group. Most states can start without video; Kansas, Louisiana, Mississippi, New Mexico and West Virginia require a brief video or audio visit. Treatment and dose remain clinician-dependent. Sources: https://vytorahealth.com/ https://vytorahealth.com/faq
- 2. October 2026 — Product pages advertise free refill shipping, but the standalone shipping policy says charges are calculated at checkout. The policy estimates two-to-three-business-day processing and four-to-twelve-business-day shipping; no selected shipping charge is verified. The refund policy states prescription sales are final and filling errors should be reported to support. It does not establish the payment/refund result when no prescription is issued. Sources: https://vytorahealth.com/shipping https://vytorahealth.com/refund
- 3. October 2026 — Brand tirzepatide catalog names Mounjaro and Zepbound; their own administration sections explicitly name prefilled pens. These are grouped under one brand-tirzepatide/pen record rather than duplicated by brand. The product pages contain inconsistent Mounjaro indication wording; this record does not adopt the provider’s claim of weight-loss approval, and no indication is inferred from marketing. The compounding network is not assigned as the dispenser of brand products. Sources: https://vytorahealth.com/mounjaro https://vytorahealth.com/zepbound
- 4. October 2026 — Vytora publishes conflicting brand-availability statements: its current homepage and dedicated Mounjaro and Zepbound pages advertise those prescriptions, while the compounded semaglutide page says “Vytora Health does not offer brand-name products.” The conflict is unresolved; confirm that the named brand is currently available before paying. The general all-state claim is not confirmation of brand-specific eligibility or dispensing, and the brand pages’ coverage answer refers to compounding-pharmacy partners. Brand-specific state availability remains unconfirmed. Sources: https://vytorahealth.com/semaglutide https://vytorahealth.com/mounjaro https://vytorahealth.com/zepbound
4 further notes concern other Vytora Health programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.